ArticleMolecular therapy. Methods & clinical development2015

A phase 1 study of a heterologous prime-boost vaccination involving a truncated HER2 sequence in patients with HER2-expressing breast cancer.

Sung-Bae Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.